Stellaromics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $80M

  • Investors
  • 5

Stellaromics General Information

Description

Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. The company's tools use patented novel technology for identifying high-resolution three-dimensional transcription patterns in native biological tissue using hydrogel tissue chemistry, allowing researchers to conduct studies on thick tissue samples, and mapping gene expression patterns while preserving the spatial integrity and anatomical structure of the cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 321 Harrison Avenue
  • 5th Floor
  • Boston, MA 02118
  • United States
+1 (857)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 321 Harrison Avenue
  • 5th Floor
  • Boston, MA 02118
  • United States
+1 (857)

Stellaromics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stellaromics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 06-Dec-2024 $80M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Nov-2023 Completed Generating Revenue
To view Stellaromics’s complete valuation and funding history, request access »

Stellaromics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A-1
Series A 3,581,779 $0.000100 $5.58 $5.58 1x $5.58 7.63%
To view Stellaromics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Stellaromics Patents

Stellaromics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260092318-A1 Methods, compositions, and systems for target detection in situ Pending 02-Aug-2024
WO-2026030694-A2 Methods, compositions, and systems for target detection in situ Pending 02-Aug-2024
WO-2026030694-A3 Methods, compositions, and systems for target detection in situ Pending 02-Aug-2024
US-20260125743-A1 Compositions and methods for target detection Pending 23-May-2024
WO-2025245384-A1 Compositions and methods for target detection Pending 23-May-2024 G01N33/54306
To view Stellaromics’s complete patent history, request access »

Stellaromics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stellaromics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayshore Global Management Family Office Minority
Catalyst4 Venture Capital Minority
Falcon Creek Capital Venture Capital Minority
Stanford University Venture Fund Venture Capital Minority
Plaisance Capital Management Venture Capital Minority
To view Stellaromics’s complete investors history, request access »

Stellaromics FAQs

  • When was Stellaromics founded?

    Stellaromics was founded in 2022.

  • Where is Stellaromics headquartered?

    Stellaromics is headquartered in Boston, MA.

  • What is the size of Stellaromics?

    Stellaromics has 49 total employees.

  • What industry is Stellaromics in?

    Stellaromics’s primary industry is Discovery Tools (Healthcare).

  • Is Stellaromics a private or public company?

    Stellaromics is a Private company.

  • What is the current valuation of Stellaromics?

    The current valuation of Stellaromics is .

  • What is Stellaromics’s current revenue?

    The current revenue for Stellaromics is .

  • How much funding has Stellaromics raised over time?

    Stellaromics has raised $105M.

  • Who are Stellaromics’s investors?

    Bayshore Global Management, Catalyst4, Falcon Creek Capital, Stanford University Venture Fund, and Plaisance Capital Management have invested in Stellaromics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process